Resultados de la búsqueda 561-570 of 20631 for cesarean section

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients will receive VSL#3® 450B sachets probiotics, which will be provided as part of this trial, at least 3 days but preferably 1-2 weeks prior to ...

  2. Centros vasculares - Médicos - Mayo Clinic

    Mostrando 1-6 de 6 médicos disponibles. Inicial del apellido: C. Ana I. Casanegra, M.D., M.S.. internista; especialista en medicina ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients will receive VSL#3® 450B sachets probiotics, which will be provided as part of this trial, at least 3 days but preferably 1-2 weeks prior to ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients will receive VSL#3® 450B sachets probiotics, which will be provided as part of this trial, at least 3 days but preferably 1-2 weeks prior to ...

  5. Cirugía cardiovascular - Médicos - Mayo Clinic

    Mostrando 1-1 de 1 médicos disponibles. Inicial del apellido: C ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients will receive VSL#3® 450B sachets probiotics, which will be provided as part of this trial, at least 3 days but preferably 1-2 weeks prior to ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

  9. Medicina Física y Rehabilitación - Ensayos clínicos - Mayo Clinic

    ... part of their medical care. A Study to Evaluate Prevalence of Secondary Adrenal Insufficiency in Patients with Chronic Pain. Jacksonville, Fla. The purpose ...

  10. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...